€8.79
7.38% today
Frankfurt, Jul 21, 08:06 am CET
ISIN
SE0017769995
Symbol
BGLA
Sector
Industry

BioGaia Target price 2025 - Analyst rating & recommendation

BioGaia Classifications & Recommendation:

Buy
83%
Hold
17%

BioGaia Price Target

Target Price €12.48
Price €9.49
Potential
Number of Estimates 3
3 Analysts have issued a price target BioGaia 2026 . The average BioGaia target price is €12.48. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 6 analysts: 5 Analysts recommend BioGaia to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the BioGaia stock has an average upside potential 2026 of . Most analysts recommend the BioGaia stock at Purchase.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million € 126.56 136.81
9.74% 8.10%
EBITDA Margin 29.26% 32.77%
15.24% 12.00%
Net Margin 24.70% 26.17%
12.35% 5.95%

3 Analysts have issued a sales forecast BioGaia 2025 . The average BioGaia sales estimate is

€137m
Unlock
. This is
8.37% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
€142m 12.81%
Unlock
, the lowest is
€133m 4.99%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 €127m 9.74%
2025
€137m 8.10%
Unlock
2026
€153m 11.77%
Unlock
2027
€171m 12.04%
Unlock

3 Analysts have issued an BioGaia EBITDA forecast 2025. The average BioGaia EBITDA estimate is

€44.8m
Unlock
. This is
24.95% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
€46.8m 30.42%
Unlock
, the lowest is
€43.3m 20.75%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 €37.0m 6.98%
2025
€44.8m 21.07%
Unlock
2026
€53.0m 18.14%
Unlock
2027
€60.4m 14.08%
Unlock

EBITDA Margin

2024 29.26% 15.24%
2025
32.77% 12.00%
Unlock
2026
34.64% 5.71%
Unlock
2027
35.27% 1.82%
Unlock

3 BioGaia Analysts have issued a net profit forecast 2025. The average BioGaia net profit estimate is

€35.8m
Unlock
. This is
29.98% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
€37.7m 36.84%
Unlock
, the lowest is
€34.3m 24.50%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 €31.3m 3.82%
2025
€35.8m 14.56%
Unlock
2026
€43.2m 20.55%
Unlock
2027
€49.0m 13.57%
Unlock

Net Margin

2024 24.70% 12.35%
2025
26.17% 5.95%
Unlock
2026
28.23% 7.87%
Unlock
2027
28.62% 1.38%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share 0.31 0.35
3.13% 12.90%
P/E 26.80
EV/Sales 5.54

3 Analysts have issued a BioGaia forecast for earnings per share. The average BioGaia EPS is

€0.35
Unlock
. This is
29.63% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
€0.37 37.04%
Unlock
, the lowest is
€0.34 25.93%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 €0.31 3.13%
2025
€0.35 12.90%
Unlock
2026
€0.43 22.86%
Unlock
2027
€0.48 11.63%
Unlock

P/E ratio

Current 35.13 26.96%
2025
26.80 23.71%
Unlock
2026
22.23 17.05%
Unlock
2027
19.57 11.97%
Unlock

Based on analysts' sales estimates for 2025, the BioGaia stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 6.01 20.71%
2025
5.54 7.74%
Unlock
2026
4.96 10.53%
Unlock
2027
4.43 10.75%
Unlock

P/S ratio

Current 6.89 17.16%
2025
6.36 7.73%
Unlock
2026
5.69 10.53%
Unlock
2027
5.08 10.75%
Unlock

Current BioGaia Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
HANDELSBANKEN CAPITAL MARKETS
Locked
Locked
Locked Jun 18 2025
HANDELSBANKEN CAPITAL MARKETS
Locked
Locked
Locked Apr 03 2025
Analyst Rating Date
Locked
HANDELSBANKEN CAPITAL MARKETS:
Locked
Locked
Jun 18 2025
Locked
HANDELSBANKEN CAPITAL MARKETS:
Locked
Locked
Apr 03 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today